je.st
news
Biotech Rival to Teva's Blockbuster Said to Seek $40 Million IPO
2014-03-24 02:04:10| Biotech - Topix.net
Mapi Pharma Group, which is developing a longer acting version of Teva's blockbuster Copaxone drug, is considering selling shares in the U.S., a person with knowledge of the matter said.
Tags: million
seek
ipo
biotech
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||